Role of calmodulin in states of altered catecholamine sensitivity.
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000818:Animals; D002118:Calcium / Q000378:metabolism / Q000494:pharmacology; D002135:Calcium-Binding Proteins / Q000502:physiology*; D002147:Calmodulin / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*; D002148:Calmodulin-Binding Proteins; D002352:Carrier Proteins / Q000378:metabolism; D002395:Catecholamines / Q000502:physiology*; D002462:Cell Membrane / Q000378:metabolism; D003342:Corpus Striatum / Q000378:metabolism*; D004298:Dopamine / Q000494:pharmacology; D004533:Egtazic Acid / Q000494:pharmacology; D004789:Enzyme Activation; D006165:Guanylyl Imidodiphosphate / Q000494:pharmacology; D007700:Kinetics; D008297:Male; D051381:Rats; D014268:Trifluoperazine / Q000494:pharmacology
D002135:Calcium-Binding Proteins; D002147:Calmodulin; D002148:Calmodulin-Binding Proteins; D002352:Carrier Proteins; D002395:Catecholamines; D014268:Trifluoperazine; D006165:Guanylyl Imidodiphosphate; D004533:Egtazic Acid; D000262:Adenylyl Cyclases; D002118:Calcium; D004298:Dopamine